1. Home
  2. GH vs FNB Comparison

GH vs FNB Comparison

Compare GH & FNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$101.92

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Logo F.N.B. Corporation

FNB

F.N.B. Corporation

HOLD

Current Price

$17.50

Market Cap

6.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GH
FNB
Founded
2011
1864
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
14.1B
6.0B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
GH
FNB
Price
$101.92
$17.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
8
Target Price
$82.76
$18.31
AVG Volume (30 Days)
2.2M
4.7M
Earning Date
10-29-2025
01-21-2026
Dividend Yield
N/A
2.74%
EPS Growth
N/A
28.48
EPS
N/A
1.40
Revenue
$902,569,000.00
$1,587,400,000.00
Revenue This Year
$34.72
$17.82
Revenue Next Year
$26.46
$8.12
P/E Ratio
N/A
$12.51
Revenue Growth
30.38
6.34
52 Week Low
$29.91
$10.88
52 Week High
$112.43
$17.75

Technical Indicators

Market Signals
Indicator
GH
FNB
Relative Strength Index (RSI) 55.40 70.05
Support Level $100.21 $16.34
Resistance Level $109.59 $17.75
Average True Range (ATR) 4.22 0.33
MACD -1.65 0.10
Stochastic Oscillator 13.51 86.81

Price Performance

Historical Comparison
GH
FNB

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About FNB F.N.B. Corporation

F N B Corp provides a full range of financial services, principally to consumers, corporations, governments and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.

Share on Social Networks: